Zenapax (daclizumab) reduces the incidence of acute rejection episodes and improves patient survival following renal transplantation. No 14874 and No 14393 Zenapax Study Groups.
作者信息
Ekberg H, Bäckman L, Tufveson G, Tydén G
机构信息
Lund University, Malmo, Sweden.
出版信息
Transplant Proc. 1999 Feb-Mar;31(1-2):267-8. doi: 10.1016/s0041-1345(98)01529-2.
Abstract
摘要
Zotero 插件